Skip to content

The effect on embryo-quality of rLH-addition to rFSH for controlled ovarian hyperstimulation in women with poor ovarian reserve

The effect on embryo-quality of rLH-addition to rFSH for controlled ovarian hyperstimulation in women with poor ovarian reserve - L-age study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON31586
Enrollment
220
Registered
2008-05-27
Start date
2008-02-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

subfertility

Interventions

Controlled Ovarian Hyperstimulation in a GnRH agonist long luteal protocol with (1) 300 rFSH sc daily alone or (2) 2:1 ratio rFSH : rLH i.e. 300 IU/L rFSH and 150 IU/L rLH sc Followed by a standard IV

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Women are eligible if the following apply: 1. Patients between 35 and 43 years of age 2. Patients with IOF,

Exclusion criteria

Exclusion criteria: A woman must not be entered if any of the following apply: 1. Endocrinopathological disease as: Cushing*s syndrome, adrenal hyperplasia, hyperprolactinaemia, acromegaly, hypothalamic amenorrhea, hypothyroidy, diabetes mellitus type I, PCOS 2. If not willing or able to sign the informed consent form

Design outcomes

Primary

MeasureTime frame
Primary outcome: Percentage of top-quality embryos

Secondary

MeasureTime frame
Secondary outcome Number of follicles > 14 mm on hCG day Number of retrieved oocytes Number of metaphase II oocytes Pronuclear morphology Total number of embryos Presence of early cleavage Cleavage stage morphology Number of embryos suitable for transfer Biochemical, clinical, ongoing pregnancies Live-birth rate

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)